Compound Detail
CHEMBL1533310
HISTAMINE DIHYDROCHLORIDE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
5
Targets
25
Activities
2
Assay Types
0
PK Parameters
20
Publications
8
Known Names
5
Indications
2
Mechanisms
Molecular Properties
111.2
MW (Da)
-0.09
ALogP
2
HBA
2
HBD
54.7
PSA (Ų)
0.56
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2008 |
| Availability | Unknown |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Topical analgesic | - | - | ✓ | ✓ |
| Immunoprotectant | - | - | ✓ | ✓ |
Indications
Leukemia, Myeloid, Acute Neoplasms Leukemia Melanoma Kidney Neoplasms
ATC Classification
L03AX14
histamine dihydrochloride
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: IMMUNOSTIMULANTS
Drug Warnings
Black Box Warning
metabolic toxicity
Activity Summary
Ki 17 meas. best 8.0
EC50 8 meas. best 8.48
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Histamine H3 receptor CHEMBL264 | EC50 | 8.48 | 8.48 | 3.3 | 1 |
| Histamine H3 receptor CHEMBL264 | Ki | 8.0 | 7.306 | 10.0 | 5 |
| Histamine H4 receptor CHEMBL3759 | Ki | 7.9 | 7.246 | 12.6 | 10 |
| Histamine H4 receptor CHEMBL3759 | EC50 | 7.77 | 7.62 | 17.0 | 2 |
| Histamine H4 receptor CHEMBL5657 | EC50 | 7.06 | 6.345 | 87.1 | 2 |
| Histamine H4 receptor CHEMBL5657 | Ki | 6.3 | 5.985 | 501.2 | 2 |
| Histamine H2 receptor CHEMBL2882 | EC50 | 6.0 | 5.96 | 1000.0 | 2 |
| Histamine H2 receptor CHEMBL1941 | EC50 | 5.9 | 5.9 | 1258.9 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 32420741 | 10.1021/acs.jmedchem.0c00160 | Histamine H4 receptor | 15 |
| - | 10.6019/CHEMBL5058564 | HEK-293T | 8 |
| - | 10.6019/CHEMBL5058564 | Fibroblast | 7 |
| - | 10.6019/CHEMBL5058564 | U2OS | 6 |
| 32420741 | 10.1021/acs.jmedchem.0c00160 | Histamine H3 receptor | 6 |
| 20014752 | 10.1021/tx900326k | Hepatotoxicity | 3 |
| 22216892 | 10.1021/jm201128q | Histamine H2 receptor | 3 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL5209801 | Adhesion G-protein coupled receptor F1 | 2 |
| - | 10.6019/CHEMBL5209801 | Free fatty acid receptor 4 | 2 |
| - | 10.6019/CHEMBL5209801 | CX3C chemokine receptor 1 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| - | 10.6019/CHEMBL5209801 | Glucose-dependent insulinotropic receptor | 2 |
| - | 10.6019/CHEMBL5209801 | N-formyl peptide receptor 2 | 2 |
| - | 10.6019/CHEMBL5209801 | Glucagon-like peptide 1 receptor | 2 |
| - | 10.6019/CHEMBL5209801 | G-protein coupled receptor 35 | 2 |
| - | 10.6019/CHEMBL5209801 | Sphingosine 1-phosphate receptor 1 | 2 |
| - | 10.6019/CHEMBL5209801 | Beta-2 adrenergic receptor | 2 |
| - | 10.6019/CHEMBL5209801 | C5a anaphylatoxin chemotactic receptor 1 | 2 |
| - | 10.6019/CHEMBL5209801 | Alpha-2A adrenergic receptor | 2 |
Data from ChEMBL 36 via Core Engine